CAMG
CWA Asset Management Group’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.53M | Buy |
119,450
+3,535
| +3% | +$164K | 0.23% | 100 |
|
|
2025
Q1 | $7.07M | Buy |
115,915
+4,766
| +4% | +$291K | 0.34% | 66 |
|
|
2024
Q4 | $6.29M | Buy |
111,149
+23,957
| +27% | +$1.36M | 0.32% | 70 |
|
|
2024
Q3 | $4.51M | Buy |
+87,192
| New | +$4.51M | 0.24% | 91 |
|
|
2024
Q1 | $6.37M | Buy |
117,538
+92,099
| +362% | +$4.99M | 0.39% | 63 |
|
|
2023
Q4 | $1.31M | Buy |
25,439
+17,332
| +214% | +$889K | 0.09% | 142 |
|
|
2023
Q3 | $471K | Buy |
8,107
+283
| +4% | +$16.4K | 0.03% | 226 |
|
|
2023
Q2 | $500K | Buy |
7,824
+1,485
| +23% | +$95K | 0.03% | 218 |
|
|
2023
Q1 | $439K | Sell |
6,339
-3,469
| -35% | -$240K | 0.03% | 215 |
|
|
2022
Q4 | $706K | Sell |
9,808
-245
| -2% | -$17.6K | 0.06% | 158 |
|
|
2022
Q3 | $715K | Buy |
10,053
+140
| +1% | +$9.96K | 0.07% | 138 |
|
|
2022
Q2 | $763K | Sell |
9,913
-13
| -0.1% | -$1K | 0.07% | 140 |
|
|
2022
Q1 | $725K | Buy |
9,926
+3,684
| +59% | +$269K | 0.06% | 152 |
|
|
2021
Q4 | $389K | Sell |
6,242
-728
| -10% | -$45.4K | 0.03% | 208 |
|
|
2021
Q3 | $412K | Buy |
6,970
+619
| +10% | +$36.6K | 0.03% | 197 |
|
|
2021
Q2 | $423K | Sell |
6,351
-669
| -10% | -$44.6K | 0.03% | 189 |
|
|
2021
Q1 | $443K | Buy |
7,020
+5
| +0.1% | +$316 | 0.04% | 176 |
|
|
2020
Q4 | $435K | Sell |
7,015
-454
| -6% | -$28.2K | 0.05% | 177 |
|
|
2020
Q3 | $450K | Sell |
7,469
-869
| -10% | -$52.4K | 0.06% | 144 |
|
|
2020
Q2 | $490K | Sell |
8,338
-973
| -10% | -$57.2K | 0.09% | 122 |
|
|
2020
Q1 | $519K | Sell |
9,311
-1,353
| -13% | -$75.4K | 0.1% | 115 |
|
|
2019
Q4 | $685K | Buy |
+10,664
| New | +$685K | 0.11% | 112 |
|